Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Wei-Xiang Qi"'
Autor:
Yi-min Han, Dan Ou, Wei-min Chai, Wen-lei Yang, Ying-long Liu, Ji-feng Xiao, Wei Zhang, Wei-xiang Qi, Jia-yi Chen
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e29350- (2024)
Objectives: This study aimed to explore the spatial distribution of brain metastases (BMs) from breast cancer (BC) and to identify the high-risk sub-structures in BMs that are involved at first diagnosis. Methods: Magnetic resonance imaging (MRI) sca
Externí odkaz:
https://doaj.org/article/eccee95376c045ca8d97a598704686c9
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundWe aim to evaluate the value of an integrated multimodal radiomics with machine learning model to predict the pathological complete response (pCR) of primary tumor in a prospective cohort of esophageal squamous cell carcinoma (ESCC) treated
Externí odkaz:
https://doaj.org/article/ce176c498e4b47fb86b5d7a9ccd4d0c5
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13309-13318 (2023)
Abstract Background and Objectives Neoadjuvant chemotherapy (nCT) appears in a few clinical studies as an alternative to neoadjuvant chemoradiation (nCRT) in selected patients with locally advanced rectal cancer (LARC). We aimed to compare the clinic
Externí odkaz:
https://doaj.org/article/fd9ec9dd3e1c4122bc59367120b7c90f
Autor:
Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li, Shuyan Li, Huan Li, Feifei Xu, Jiayi Chen, Shengguang Zhao, Hecheng Li
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1556-1566 (2023)
Abstract Background The aim of the study was to analyze the relationship between pretreatment inflammatory biomarkers (IBs) and survival outcomes for patients with esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoradiotherapy (
Externí odkaz:
https://doaj.org/article/0bbd9df068ba46e4b632d2e1c1bf1908
Autor:
Si-Yue Zheng, Chu-Ying Chen, Wei-Xiang Qi, Gang Cai, Cheng Xu, Rong Cai, Xiao-Fang Qian, Kun-Wei Shen, Lu Cao, Jia-Yi Chen
Publikováno v:
Breast, Vol 68, Iss , Pp 142-148 (2023)
Purpose: To explore the risk factors for breast cancer-related lymphedema (BCRL) and upper extremity dysfunction (UED) in patients with early breast cancer after modern comprehensive treatment and to compare the toxicity of different treatment strate
Externí odkaz:
https://doaj.org/article/9dee56a385514a059da47045e51297a6
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Since the publication of MA-20 and EORTC-22922 trials, chest wall (CW)/ whole breast (WB) irradiation + comprehensive regional nodal irradiation (RNI) with internal mammary node irradiation (IMNI) has been the standard adjuvant tr
Externí odkaz:
https://doaj.org/article/d1d5836c4ef8419daa238a558d76a340
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundCurrently, the optimal adjuvant regional nodal irradiation (RNI) volume for breast cancer (BC) remained controversial. We aimed to define the optimal RNI treatment volume for BC by using a comprehensive network meta-analysis (NMA) of publis
Externí odkaz:
https://doaj.org/article/812bac62043f472f91aaa90288fcfbf7
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe aim of this study is to assess the clinical benefit of postoperative radiotherapy (PORT) in patients with esophageal cancer (EC) who treated with neoadjuvant chemotherapy (NAC) and surgery via a national population-based database.Method
Externí odkaz:
https://doaj.org/article/3d0083b0f3f14d7793ae8169122c76dd
Autor:
Min Li, Fei Xu, Jian Li, Min Chen, Mei Chen, Cheng Xu, Yuan Yao, Rong Cai, Qing Lin, Xiao Lin, Yimin Han, Feifei Xu, Jinrong Xie, Yutian Zhao, Gang Cai, Qiwei Zhu, Shubei Wang, Xiaolu Tang, Chuying Chen, Siyue Zheng, Xiaofang Qian, Chunhong Shen, Haoping Xu, Dan Ou, Kun Wei Shen, Wei-Xiang Qi, Lu Cao, Xiaobo Huang, Jiayi Chen
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Introduction Short course regimen has become the major trend in the field of adjuvant radiotherapy for patients with breast cancer. Hypofractionated radiotherapy (HF-RT) regimen of 40–42.5 Gy in 15–16 fractions has been established as a preferred
Externí odkaz:
https://doaj.org/article/f8c3414812cc4aa491dac125758d6992
Autor:
Lu Cao, Cheng Xu, Meng-Di Wang, Wei-Xiang Qi, Gang Cai, Rong Cai, Shu-Bei Wang, Dan Ou, Min Li, Kun-Wei Shen, Jia-Yi Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo determine the relationship between time to radiotherapy (TTR) and survival outcomes in breast cancer (BC) patients treated with neoadjuvant treatments (NATs).MethodsContinuous non-metastatic BC patients receiving NAT and adjuvant radiothera
Externí odkaz:
https://doaj.org/article/abaf1e74173d4295810b54672febd5b2